Financhill
Back

Vaxcyte Stock Predictions

Vaxcyte Stock Forecast

  • Over the next 52 weeks, Vaxcyte has on average historically risen by 42.1% based on the past 4 years of stock performance.
  • Vaxcyte has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Vaxcyte Stock Undervalued?
    The current Vaxcyte [PCVX] share price is $87.72. The Score for PCVX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • PCVX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Vaxcyte Stock Go Up Next Year?

  • Over the next 52 weeks, Vaxcyte has on average historically risen by 42.1% based on the past 4 years of stock performance.

Vaxcyte Stock Rating

Sell
47
Vaxcyte (PCVX) is a Sell

Is Vaxcyte overpriced?

  • Vaxcyte has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Vaxcyte Stock Price History

Is PCVX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PCVX is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vaxcyte.com

52-Week Data

52-Week High:
121.06
52-Week Low:
53.83

Prediction Charts

Market Cap:
10.93B
Price in USD:
87.72
Volume:
958.62K
Beta:
0.96

Technical Analysis

SMA50:
101.36
SMA100:
97.75
SMA200:
84.11
52-Wk Change:
48.08%

Stock Predictions

  • Is Vaxcyte stock public?
    Yes, Vaxcyte is a publicly traded company.
  • What is the Vaxcyte stock quote today?
    The Vaxcyte stock price is 87.72 USD today.
  • How to buy Vaxcyte stock online?
    You can buy Vaxcyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-25 89.27 91.70 92.15 89.06
Nov-26 91.49 91.45 92.61 90.70
Nov-27 91.88 93.98 94.05 90.73
Nov-29 93.89 94.34 94.38 91.97
Dec-2 94.01 91.60 94.76 91.36
Dec-3 91.09 90.37 93.38 90.17
Dec-4 90.02 93.04 93.49 89.58
Dec-5 92.75 90.04 93.23 89.33
Dec-6 90.22 93.31 93.98 90.00
Dec-9 93.68 92.06 94.60 91.39
Dec-10 92.55 90.43 93.78 90.00
Dec-11 90.84 91.05 92.29 90.22
Dec-12 90.61 87.87 90.91 87.43
Dec-13 87.52 87.72 89.65 86.80

Vaxcyte Earnings

Vaxcyte Earnings Report: Per Share Vaxcyte Earnings Q1 Q2 Q3 and Q4 last year and next year.

Vaxcyte Forecast Revenue Growth

Vaxcyte Stock Analysis: Historical quarterly revenues per share for Vaxcyte and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.54 per share, and a decrease next year of $0.85 per share.

* Vaxcyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.